화학공학소재연구정보센터
검색결과 : 8건
No. Article
1 Neuropilin-1 facilitates SARS-CoV-2 cell entry and infectivity
Cantuti-Castelvetri L, Ojha R, Pedro LD, Djannatian M, Franz J, Kuivanen S, van der Meer F, Kallio K, Kaya T, Anastasina M, Smura T, Levanov L, Szirovicza L, Tobi A, Kallio-Kokko H, Osterlund P, Joensuu M, Meunier FA, Butcher SJ, Winkler MS, Mollenhauer B, Helenius A, Gokce O, Teesalu T, Hepojoki J, Vapalahti O, Stadelmann C, Balistreri G, Simons M
Science, 370(6518), 856, 2020
2 Neuropilin-1 is a host factor for SARS-CoV-2 infection
Daly JL, Simonetti B, Klein K, Chen KE, Williamson MK, Anton-Plagaro C, Shoemark DK, Simon-Gracia L, Bauer M, Hollandi R, Greber UF, Horvath P, Sessions RB, Helenius A, Hiscox JA, Teesalu T, Matthews DA, Davidson AD, Collins BM, Cullen PJ, Yamauchi Y
Science, 370(6518), 861, 2020
3 Phage-Display-Derived Peptide Binds to Human CD206 and Modeling Reveals a New Binding Site on the Receptor
Asciutto EK, Kopanchuk S, Lepland A, Simon-Gracia L, Aleman C, Teesalu T, Scodeller P
Journal of Physical Chemistry B, 123(9), 1973, 2019
4 Rab11 and Lysotracker Markers Reveal Correlation between Endosomal Pathways and Transfection Efficiency of Surface-Functionalized Cationic Liposome-DNA Nanoparticless
Majzoub RN, Wonder E, Ewert KK, Kotamraju VR, Teesalu T, Safinya CR
Journal of Physical Chemistry B, 120(26), 6439, 2016
5 Etchable plasmonic nanoparticle probes to image and quantify cellular internalization
Braun GB, Friman T, Pang HB, Pallaoro A, de Mendoza TH, Willmore AMA, Kotamraju VR, Mann AP, She ZG, Sugahara KN, Reich NO, Teesalu T, Ruoslahti E
Nature Materials, 13(9), 904, 2014
6 Sequence dependence of C-end rule peptides in binding and activation of neuropilin-1 receptor
Zanuy D, Kotla R, Nussinov R, Teesalu T, Sugahara KN, Aleman C, Haspel N
Journal of Structural Biology, 182(2), 78, 2013
7 A high-throughput label-free nanoparticle analyser
Fraikin JL, Teesalu T, McKenney CM, Ruoslahti E, Cleland AN
Nature Nanotechnology, 6(5), 308, 2011
8 Coadministration of a Tumor-Penetrating Peptide Enhances the Efficacy of Cancer Drugs
Sugahara KN, Teesalu T, Karmali PP, Kotamraju VR, Agemy L, Greenwald DR, Ruoslahti E
Science, 328(5981), 1031, 2010